256 related articles for article (PubMed ID: 804494)
21. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
[TBL] [Abstract][Full Text] [Related]
22. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
[TBL] [Abstract][Full Text] [Related]
23. [Hemorheologic disturbances and circulating immune complexes in patients with rheumatic diseases].
Loskutova TT; Koreshkov GG; Nasonov EL; Zakharchenko VN; Larionov SM
Ter Arkh; 1989; 61(5):51-5. PubMed ID: 2781490
[No Abstract] [Full Text] [Related]
24. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
Waterman SA; Gordon TP; Rischmueller M
Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771
[TBL] [Abstract][Full Text] [Related]
25. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
Ebo D; DeClerck LS; Bridts CH; Stevens WJ
In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
[TBL] [Abstract][Full Text] [Related]
26. Sensitivity and specificity of anti-alpha-fodrin antibodies in primary Sjögren's syndrome.
Szántó A; Csípo I; Zeher M
J Rheumatol; 2005 Jan; 32(1):197; author reply 197-8. PubMed ID: 15630756
[No Abstract] [Full Text] [Related]
27. [Antibodies against soluble nuclear antigens of the SS-A or SS-B type. Significance in systemic lupus erythematosis (author's transl)].
Meyer O; Haim T
Nouv Presse Med; 1981 Jun; 10(26):2179-84. PubMed ID: 6973748
[TBL] [Abstract][Full Text] [Related]
28. Antibodies against SS-B/La and SS-A/Ro antigens in patients with primary Sjögren's syndrome.
Hansen B; Manthorpe R
Scand J Rheumatol Suppl; 1986; 61():93-7. PubMed ID: 3495875
[TBL] [Abstract][Full Text] [Related]
29. Antibody to a soluble acidic nuclear antigen in Sjögren's syndrome.
Kassan SS; Akizuki M; Steinberg AD; Reddick RL; Chused TM
Am J Med; 1977 Sep; 63(3):328-35. PubMed ID: 409286
[No Abstract] [Full Text] [Related]
30. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus.
Provost TT; Talal N; Harley JB; Reichlin M; Alexander E
Arch Dermatol; 1988 Jan; 124(1):63-71. PubMed ID: 3257371
[TBL] [Abstract][Full Text] [Related]
31. Antibodies to AB blood group antigens mimic anti-salivary duct autoantibodies in patients with limited sicca symptoms.
Goldblatt F; Beroukas D; Gillis D; Cavill D; Bradwell A; Rischmueller M; Gordon TP
J Rheumatol; 2000 Oct; 27(10):2382-8. PubMed ID: 11036834
[TBL] [Abstract][Full Text] [Related]
32. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
[TBL] [Abstract][Full Text] [Related]
33. Anti-p53 antibodies are rarely detected in serum of patients with rheumatoid arthritis and Sjögren's syndrome.
Mariette X; Sibilia J; Delaforge C; Bengoufa D; Brouet JC; Soussi T
J Rheumatol; 1999 Aug; 26(8):1672-5. PubMed ID: 10451060
[TBL] [Abstract][Full Text] [Related]
34. Genetic studies of anti-Ro (SSA) antibodies in families with rheumatoid arthritis.
Tishler M; Moutsopoulos HM; Yaron M
J Rheumatol; 1992 Feb; 19(2):234-6. PubMed ID: 1629820
[TBL] [Abstract][Full Text] [Related]
35. [Association of systemic lupus erythematosus and Sjögren's syndrome].
Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
[TBL] [Abstract][Full Text] [Related]
36. [Inhibitory effect of sera from patients with rheumatic diseases on EA-rosette formation].
Nasonov EL; Aleksandrova EN; Sura VV; Ivanova MM; Zimin IuI
Ter Arkh; 1983; 55(7):32-7. PubMed ID: 6604958
[No Abstract] [Full Text] [Related]
37. Profiles of antibodies to histones, DNA and IgG in patients with systemic rheumatic diseases determined by ELISA.
Gripenberg M; Helve T; Kurki P
J Rheumatol; 1985 Oct; 12(5):934-9. PubMed ID: 3878880
[TBL] [Abstract][Full Text] [Related]
38. [Detection of antibodies to extractable nuclear antigens with counterimmunoelectrophoresis and the Western blot technic].
Hauke G; Lührmann R; Metz B; Peter HH
Z Rheumatol; 1988; 47(1):26-9. PubMed ID: 3259356
[TBL] [Abstract][Full Text] [Related]
39. Predictive value of SS-B precipitating antibodies in Sjoögren's syndrome.
Isenberg DA; Hammond L; Fisher C; Griffiths M; Stewart J; Bottazzo GF
Br Med J (Clin Res Ed); 1982 Jun; 284(6331):1738-40. PubMed ID: 6805691
[TBL] [Abstract][Full Text] [Related]
40. Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Demonstration by precipitation and immunofluorescence.
Aslpaugh MA; Tan EM
Arthritis Rheum; 1976; 19(4):711-9. PubMed ID: 1085148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
